LEGN SEC Filings: 8-K, 10-Q, S-3 & 424B – Legend Biotech

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 10, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 11, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 19, 2024

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 29, 2023

20-F/A

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

Feb 17, 2023

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 31, 2022

News

TYPE

HEADLINE

FILED AT

6-K

Legend Biotech to Showcase CARVYKTI Leadership and Next-Generation Cell Therapy Innovation at ASH 2026

Nov 4, 2026

6-K

Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy

Oct 15, 2026

6-K

Legend Biotech Announces Preliminary Q3 2026 Sales for CARVYKTI®

Oct 13, 2026

6-K

Legend Biotech Presents Five-Year CARVYKTI Data Showing 50% Progression-Free Survival in Relapsed/Refractory Multiple Myeloma

Sep 25, 2026

6-K

Legend Biotech Corporation Announces Voting Results from 2026 Annual General Meeting

Sep 24, 2026

6-K

Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer

Sep 15, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Jun 18, 2026

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Jun 17, 2026

424B5

Representing 10,937,500 Ordinary Shares

May 8, 2023

424B5

8,140,000 American Depositary Shares

Jul 27, 2022

424B5

$250,000,000

Jul 25, 2022

424B5

7,500,000 American Depositary Shares-

Dec 17, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Oct 7, 2026

F-6EF

Form F-6EF - Registration of American Depository Receipt shares, immediately effective

Jun 17, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Nov 14, 2024

F-3ASR

As of December 31, 2023, we had 363,822,069 ordinary shares issued and outstanding.

Mar 19, 2024

F-3ASR

8,834,742 Ordinary Shares

May 26, 2023

Form D - Notice of Exempt Offering of Securities - Item 06b

Apr 28, 2023

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

Sep 16, 2024

CORRESP

Form CORRESP - Correspondence

Sep 11, 2024

LETTER

Form UPLOAD - SEC-generated letter

Sep 4, 2024

LETTER

Form UPLOAD - SEC-generated letter

Sep 15, 2023

CORRESP

Form CORRESP - Correspondence

Sep 8, 2023

LETTER

Form UPLOAD - SEC-generated letter

Aug 31, 2023

Legend Biotech Corporation LEGN · SEC Filings